About
Sanavia Oncology develops next-generation cancer therapies by combining immunology with AI to rapidly discover novel epitopes and create targeted antibody drug conjugates, bispecific T cell engagers, and CAR-T cell therapies.
Explore Sanavia Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.